1. Lemberger L., Witt E.D., Davis J.M. and Kopin I.J. (1970): The effects of haloperidol and chlorpromazine on amphetamine metabolism and amphetamine stereotype behavior in the rat. J. Pharmacol. Exp. Ther.,174, 428–433.
2. Shah N.S., Shah K.R., Lawrence R.S. and Neely A.E. (1973): Effects of chlorpromazine and haloperidol on the disposition of mescaline-14C in mice. J. Pharmacol. Exp. Ther.,186, 297–304.
3. Shah N.S., Jacobs J.R., Jones J.T. and Hedden M.P. (1975): Interaction of mescaline with phenothiazines: Effect on behavior, body temperature, and tissue levels of hallucinogen in mice. Biological Psychiatry,10, 561–573.
4. Shah N.S., Kamano A., Glisson S. and Callison D. (1968): Studies on the uptake of radiolabeled DOPA, 5-HTP and tryptophan in rat tissues in vivo: Effect of methionine, tryptophan and some keto acids. Int. J. Neuropharmacol.,7, 75–86.
5. Charalampous K.D., Walker K.E. and Kinross-Wright J. (1966): Metabolic fate of mescaline in man. Psychopharmacologia,9, 48–63.